Leuven

City
Favicons?domain=wwwMedical News Today | 6 days ago

ThromboGenics And BioInvent Complete Phase I Patient Trial Of Anti-PlGF Cancer Therapeutic TB-403 In Patients With Advanced Solid Tumours

...for Biotechnology (VIB) and has exclusive rights to certain therapeutics developed at these institutions. ThromboGenics is headquartered in Leuven, Belgium. The Company is listed on Eurolist by Euronext Brussels under the symbol THR. About...

In this article: Cancer, Medical advice, and Genentech

Connections-toggle
Filter by
or